SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Director Lawrence Klein filed a Form 144 notice of intent to sell…

Oruka Therapeutics, Inc. · 144 filed Nov 2, 2026 at 16:39 ET

At the news

NEUTRALIMPACT 3/10

144 filed Nov 2, 2026 at 16:39 ET

Director Lawrence Klein filed a Form 144 notice of intent to sell 25,000 shares of Oruka Therapeutics common stock, with an estimated aggregate market value of approximately $2.42 million based on the filing price. The sale is planned for November 2, 2026, and the shares were acquired through the exercise of stock options. Klein has a history of recent sales under a 10b5-1 plan, including 75,000 shares sold on September 1, 2026, and 25,000 shares sold on October 1, 2026, totaling over $9 million in recent dispositions.

  • Director Lawrence Otto Klein filed Form 144 to sell 25,000 shares of Oruka Therapeutics common stock.
  • Estimated aggregate market value of the proposed sale is $2,421,750.
  • Shares were acquired via exercise of stock options on November 2, 2026.
  • Klein has sold 100,000 shares in the prior two months under a 10b5-1 plan (75,000 on Sep 1, 2026 and 25,000 on Oct 1, 2026).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access